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ABSTRACT 
Antibiotic resistance is a serious and growing phenomenon in contemporary 
medicine and has emerged as one of the pre-eminent public health concerns of the 
21st century. Antibiotic resistance is a form of drug resistance whereby some (or, less 
commonly, all) sub-populations of a microorganism, usually a bacterial species, are 
able to survive after exposure to one or more antibiotics; pathogens resistant to 
multiple antibiotics are considered multidrug resistant (MDR) or, more colloquially, 
superbugs. However, the increasing prevalence of antibiotic-resistant bacterial 
infections seen in clinical practice stems from antibiotic use both within human 
medicine and veterinary medicine. According to a new report by the U.S. Centers for 
Disease Control and Prevention (CDC), at least 2 million people in the United States 
develop serious bacterial infections that are resistant to one or more types of 
antibiotics each year, and at least 23,000 die from the infections. Ayurveda refers that 
the Dosha get aggravated by exogenous or endogenous causes, which further spread 
in body by the using improper foods and activities. It vitiates kosthagni (Metabolic 
enzymes) which leads to improper digestion production of Ama (toxin) and their 
minute Srotas (body channels) this is called shrotodushtie (Disequilibrium in 
channels). When the Rasadhatu (plasma and lymph) containing Ama (toxin) and 
aggravated Doshas reaches the place where Kha Vaigunya (movement tendency 
towards empty space) has taken place, it being unable to get into the minute 
channels, gets obstructed, stagnates/accumulates there and gives rise to such 
diseases caused by exogenous causes. That is why, Ayurveda advocates enhancing the 
immunity against the diseases. Several plant extracts have exhibited synergistic 
activity against microorganisms. The Indian plants possessing significant anti-
microbial activity are Neem (Azadirachta indica), Pippali (Piper longum), Guduchi 
stem (Tinospora cordifolia) and Amla fruit (Emblica officinalis), among others. The 
purpose of this paper is to outline possible ways in which certain concepts of 
Ayurveda can be used for finding remedy of emerging health problem “The Antibiotic 
Resistant Organism”. 
KEY WORDS: Ama, Rasa dhatu, Srotas, MDR, Kha-vaigunya, Sroto-dushti, Sahah bala, 
Yuktikrit bala. 
INTRODUCTION 
Ayurveda is well known as the Vedic 
system of health care of India, practiced 
effectively for thousands of years by millions of 
people.[1] The image of life as a river, an endless 
stream of processes that produce continuous 
change, yet enable the overall form to remain the 
same is consistent with the viewpoint of 
Ayurveda. Every day we breathe, eat and drink, 
and process large quantities of various kinds of 
matter, yet we may remain relatively unchanged. 
By understanding how the different processes 
involved maintain the bodily system, we may 
gain insights into its various modes of 
functioning. The river image is parallel to 
modern understandings of life based on systems 
theory[2] and non-equilibrium thermody-
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namics,[3] and points to such areas of modern 
science as possible sources of parallels to 
Ayurveda. One verse from the major text on 
Ayurveda, the Charaka Samhita[4] states 
“Ayurvedo Amritanaam,” that the purpose of 
Ayurveda is to gain immortality the longest 
lifespan of all. Most Western biomedical 
explanatory models of the body are framed in 
terms of bio-chemistry, rather than physics. In 
contrast, most traditional medical systems such 
as Ayurveda begin with “energy” for their theory 
of biologic processes, so that in essence they 
begin with physics, and move on to explaining 
biochemical and biologic levels on that basis. 
This may explain the misunderstanding, and, 
often, dismissal of such models found in modern 
Western medicine. Ayurveda advocates that a 
disease emerges by the exogenous or 
endogenous causes but finally (at biological 
level) it effects to the natural equilibrium of 
three body humors ‘Tri-dosha”, which are 
responsible for keeping healthy to a healthy 
person if they are homogenous. Further 
Ayurveda refers that Diseases caused by super 
human / subtle agencies are two types; 
Humiliated divine/subtle beings and Developing 
from proximity or contact with another disease 
person. [5] 
Antibiotic resistance Organism 
Antibiotic resistance is a serious and 
growing phenomenon in contemporary medicine 
and has emerged as one of the pre-eminent 
public health concerns of the 21st century; 
particularly as it pertains to pathogenic 
organisms (the term is especially relevant to 
organisms which cause disease in humans). It is 
said by Cesar Arias, M.D., Ph.D., the study's senior 
author and associate professor in the Division of 
Infectious Diseases at the UT Health Medical 
School.[6] According to a new report by the U.S. 
Centers for Disease Control and Prevention 
(CDC), at least 2 million people in the United 
States develop serious bacterial infections that 
are resistant to one or more types of antibiotics 
each year, and at least 23,000 die from the 
infections. [7]  
Antibiotic resistance is a form of drug 
resistance whereby some (or, less commonly, all) 
sub-populations of a microorganism, usually a 
bacterial species, are able to survive after 
exposure to one or more antibiotics; pathogens 
resistant to multiple antibiotics are considered 
multidrug resistant (MDR) or, more colloquially, 
superbugs. Microbes, rather than people, 
develop resistance to antibiotics. [8]  
Antibiotic resistant organism may take 
the form of a spontaneous or induced genetic 
mutation or the acquisition of resistance genes 
from other bacterial species by horizontal gene 
transfer via conjugation, transduction, or 
transformation. Many antibiotic resistance genes 
reside on transmissible plasmids, facilitating 
their transfer. Exposure to an antibiotic naturally 
selects for the survival of the organisms with the 
genes for resistance. In this way, a gene for 
antibiotic resistance may readily spread through 
an ecosystem of bacteria. Antibiotic-resistance 
plasmids frequently contain genes conferring 
resistance to several different antibiotics. This is 
not the case for Mycobacterium tuberculosis, the 
bacteria that causes Tuberculosis, since evidence 
is lacking for whether these bacteria have 
plasmids. [9] 
Historical Review of Antibiotic Resistance 
There is evidence that naturally occurring 
antibiotic resistance is common.  
In 1945, in his Nobel Lecture, "Penicillin," 
Alexander Fleming warned against the use of 
sub‐therapeutic doses of antibiotics – “bought by 
anyone in the shops” without a prescription: 
“The time may come when penicillin can be 
bought by anyone in the shops. Then there is the 
danger that the ignorant man may easily under-
dose he and by exposing his microbes to 
non‐lethal quantities of the drug make them 
resistant. Here is a hypothetical illustration. Mr. 
X. has a sore throat. He buys some penicillin and 
gives himself, not enough to kill the streptococci 
but enough to educate them to resist penicillin. 
He then infects his wife. Mrs. X gets pneumonia 
and is treated with penicillin. As the streptococci 
are now resistant to penicillin the treatment 
fails. Mrs. X dies. Who is primarily responsible 
for Mrs. X’s death?”[10] While experimenting at 
the University of Wisconsin-Madison, Joshua 
Lederberg and his graduate student Norton 
Zinder also demonstrated preexistent bacterial 
resistance to streptomycin. [11]  
In 1962, the presence of penicillinase 
was detected in dormant Bacillus licheniformis 
endospores, revived from dried soil on the roots 
of plants, preserved since 1689 in the British 
Museum. [12] (a,b) Six strains of Clostridium, 
found in the bowels of William Braine and John 
Hartnell (members of the Franklin Expedition) 
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showed resistance to cefoxitin and clindamycin. 
[13] It was suggested that penicillinase may have 
emerged as a defense mechanism for bacteria in 
their habitats, such as the case of penicillinase-
rich Staphylococcus aureus, living with penicillin-
producing Trichophyton, however this was 
deemed circumstantial. Search for a penicillinase 
ancestor has focused on the class of proteins that 
must be a priori capable of specific combination 
with penicillin. [14]  
Causes: In medicine, the major problem of the 
emergence of resistant bacteria is due to misuse 
and overuse of antibiotics. [15] In some countries, 
antibiotics are sold over the counter without a 
prescription, (India is one of them), which also 
leads to the creation of resistant strains. Other 
practices contributing towards resistance 
include antibiotic use in livestock feed. [16]  
Household use of anti-bacterial in soaps and 
other products, although not clearly contributing 
to resistance, is also discouraged (as not being 
effective at infection control). [17] (a,b) Unsound 
practices in the pharmaceutical manufacturing 
industry can also contribute towards the 
likelihood of creating antibiotic-resistant strains. 
The procedures and clinical practice during the 
period of drug treatment are frequently flawed - 
usually no steps are taken to isolate the patient 
to prevent re-infection or infection by a new 
pathogen, negating the goal of complete 
destruction by the end of the course. [18]  
Antibiotic resistance increasing with 
duration of treatment 
Antibiotic resistance has been shown to 
increase with duration of treatment; therefore, 
as long as a clinically effective lower limit is 
observed (that depends upon the organism and 
antibiotic in question), the use by the medical 
community of shorter courses of antibiotics is 
likely to decrease rates of resistance, reduce cost, 
and have better outcomes due to fewer 
complications such as C. difficile infection and 
diarrhea. [19] In some situations a short course is 
inferior to a long course.[20] One study found that 
with one antibiotic a short course was more 
effective, but with a different antibiotic, a longer 
course was more effective.[21] Advised to 
complete a course of antibiotics is not always 
based on strong evidence, and some researchers 
discourage the use of the prescription label 
“Finish all this medication unless otherwise 
directed by prescriber.” Often, antibiotics can be 
safely stopped 72 hours after symptoms 
resolve.[22] However, some infections require 
treatments long after symptoms are gone, and in 
all cases, an insufficient course of antibiotics may 
lead to relapse (with an infection that is now 
more antibiotic resistant).[23]  
As we aware that the Patients taking less 
than the required dosage or failing to take their 
doses within the prescribed timing results in 
decreased concentration of antibiotics in the 
bloodstream and tissues, and, in turn, exposure 
of bacteria to suboptimal antibiotic 
concentrations increases the frequency of 
antibiotic resistant organisms.[24] A large number 
of people do not finish a course of antibiotics 
primarily because they feel better (varying from 
10% to 44%, depending on the country).[25] 
There is a bdlief that compliance with once-daily 
antibiotics is better than with twice-daily 
antibiotics.[26] Hence, it is required that the 
Doctors must provide instructions to patients so 
they know when it is safe to stop taking a 
prescription since patients may feel better 
before the infection is eradicated. Some 
researchers advocate doctors' using a very short 
course of antibiotics, reevaluating the patient 
after a few days, and stopping treatment if there 
are no longer clinical signs of infection.[27]  
Antibiotic resistance Mechanisms 
Antibiotic resistance can be a result of 
horizontal gene transfer,[28] and also of unlinked 
point mutations in the pathogen genome at a 
rate of about 1 in 108 per chromosomal 
replication. The antibiotic action against the 
pathogen can be seen as an environmental 
pressure. Those bacteria with a mutation, allows 
them to survive live to reproduce. They then 
pass this trait to their offspring, which leads to 
the evolution of a fully resistant colony. 
The four main mechanisms by which 
microorganisms exhibit resistance to 
antimicrobials are: 
 Drug inactivation or modification: for 
example, enzymatic deactivation of penicillin 
G in some penicillin-resistant bacteria 
through the production of β-lactamases 
 Alteration of target site: for example, 
alteration of PBP the binding target site of 
penicillins-in MRSA and other penicillin-
resistant bacteria. 
 Alteration of metabolic pathway: for example, 
some sulfonamide-resistant bacteria do not 
require para-aminobenzoic acid (PABA), an 
important precursor for the synthesis of folic 
acid and nucleic acids in bacteria inhibited by 
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sulfonamides, instead, like mammalian cells, 
they turn to using preformed folic acid. 
 Reduced drug accumulation: by decreasing 
drug permeability and/or increasing active 
efflux (pumping out) of the drugs across the 
cell surface. [29]  
Antibiotic resistance can also be 
introduced artificially into a microorganism 
through laboratory protocols, sometimes used as 
a selectable marker to examine the mechanisms 
of gene transfer or to identify individuals that 
absorbed a piece of DNA that included the 
resistance gene and another gene of interest. A 
recent study demonstrated that the extent of 
horizontal gene transfer among Staphylococcus 
is much greater than previously expected and 
encompasses genes with functions beyond 
antibiotic resistance and virulence, and beyond 
genes residing within the mobile genetic 
elements. [30] For a long time it has been thought 
that for a microorganism to become resistant to 
an antibiotic, it must be in a large population.  
However, recent findings show that there 
is no necessity of large populations of bacteria 
for the appearance of antibiotic resistance. We 
know now, that small populations of E.coli in an 
antibiotic gradient can become resistant. Any 
heterogeneous environment with respect to 
nutrient and antibiotic gradients may facilitate 
the development of antibiotic resistance in small 
bacterial populations and this is also true for the 
human body. Researchers hypothesize that the 
mechanism of resistance development is based 
on four SNP mutations in the genome of E.coli 
produced by the gradient of antibiotic. These 
mutations confer the bacteria emergence of 
antibiotic resistance. A common misconception 
is that a person can become resistant to certain 
antibiotics. It is a strain of microorganism that 
can become resistant, not a person's body. [31] 
Antibiotic-tolerant states 
Antibiotic-tolerant states may depend on 
physiological adaptations without direct 
connections to antibiotic target activity or to 
drug uptake, efflux, or inactivation. Identifying 
these adaptations, and targeting them to 
enhance the activity of existing drugs, is a 
promising approach to mitigate the public health 
crisis caused by the scarcity of new antibiotics. 
Poor hand hygiene by hospital staff has been 
associated with the spread of resistant 
organisms, [32] and an increase in hand washing 
compliance results in decreased rates of these 
organisms. [33]  
What is a "superbug"? 
The term "superbug" is a nonspecific 
word that is used to describe any microorganism 
that is resistant to at least one or more 
commonly used antibiotics. Some authors 
restrict its use to microorganisms resistant to 
two or more antibiotics. Unfortunately, the term 
superbug is used in the medical and popular 
press to describe several different types of 
organisms which can lead readers to be confused 
about specific diseases and the infectious agents 
that cause them. Depending on the type of 
bacteria, "Superbugs," just by coexisting in the 
same environment (manure piles, contaminated 
water, in the throats or colons of infected 
patients, or hospital staff carriers) have the 
ability to share antibiotic resistant genes by the 
transmission of plasmids, sometimes referred to 
as "gene jumping." Certain antibiotic classes are 
highly associated with colonization with 
"superbugs" compared to other antibiotic 
classes. A superbug, also called multi-resistant, is 
a bacterium that carries several resistance genes. 
[34]  
The most common bacteria described as 
superbugs are the following: 
1. The growing prevalence and incidence of 
infections due to MDR (Multi Drug 
Resistant) pathogens is epitomized by the 
increasing number of familiar acronyms 
used to describe the causative agent and 
sometimes the infection generally; of these, 
MRSA (Methicillin-resistant Staphylococcus 
aureus) is probably the most well-known. 
2. But others including VISA (vancomycin-
intermediate S. aureus) 
3. VRSA (vancomycin-resistant S. aureus) 
4. ESBL (Extended spectrum beta-lactamase) 
5. VRE (Vancomycin-resistant Enterococcus)  
6. MRAB (Multidrug-resistant A. baumannii) 
are prominent examples.  
Nosocomial infections overwhelmingly 
dominate cases where MDR pathogens are 
implicated, but multidrug-resistant infections 
are also becoming increasingly common in the 
community. [35] Although there were low levels of 
preexisting antibiotic-resistant bacteria before 
the widespread use of antibiotics,[36](a,b) 
evolutionary pressure from their use has played 
a role in the development of multidrug 
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resistance varieties and the spread of resistance 
between bacterial species. [37] 
Alternatives 
(A) Prevention: Rational use of antibiotics may 
reduce the chances of development of 
opportunistic infection by antibiotic-
resistant bacteria due to dysbacteriosis. Our 
immune systems will cure minor bacterial 
infections on their own. If we give it the 
chance without relying on antibiotics to 
cure a small infection, we will be less likely 
to become immune or resistant to the 
antibiotic. It is also important to note that 
antibiotics will not cure viral infections. 
These are the preventive approaches which 
might help in this regard: 
i. Vaccines: Vaccines do not have the problem 
of resistance because a vaccine enhances 
the body's natural defenses, while an 
antibiotic operates separately from the 
body's normal defenses. Nevertheless, new 
strains may evolve that escape immunity 
induced by vaccines; for example an 
updated influenza vaccine is needed each 
year. While theoretically promising, anti-
staphylococcal vaccines have shown limited 
efficacy, because of immunological variation 
between Staphylococcus species, and the 
limited duration of effectiveness of the 
antibodies produced. Development and 
testing of more effective vaccines is under 
way. [38] 
ii. Others: The Australian Commonwealth 
Scientific and Industrial Research 
Organization (CSIRO), realizing the need for 
the reduction of antibiotic use, have been 
working on two alternatives. One 
alternative is to prevent diseases by adding 
cytokines instead of antibiotics to animal 
feed. [39] These proteins are made in the 
animal body "naturally" after a disease and 
are not antibiotics, so they do not contribute 
to the antibiotic resistance problem. 
Furthermore, studies on using cytokines 
have shown they also enhance the growth of 
animals like the antibiotics now used, but 
without the drawbacks of non therapeutic 
antibiotic use. Cytokines have the potential 
to achieve the animal growth rates 
traditionally sought by the use of antibiotics 
without the contribution of antibiotic 
resistance associated with the widespread 
nontherapeutic uses of antibiotics currently 
used in the food animal production 
industries. Additionally, CSIRO is working 
on vaccines for diseases. [40] 
iii. (B).  Phage therapy: Phage therapy, an 
approach that has been extensively 
researched and used as a therapeutic agent 
for over 60 years, especially in the Soviet 
Union, represents a potentially significant 
but currently underdeveloped approach to 
the treatment of bacterial disease. [41] Phage 
therapy was widely used in the United 
States until the discovery of antibiotics, in 
the early 1940s. Bacteriophages or "phages" 
are viruses that invade bacterial cells and, in 
the case of lytic phages, disrupt bacterial 
metabolism and cause the bacterium to lyse. 
Phage therapy is the therapeutic use of lytic 
bacteriophages to treat pathogenic bacterial 
infections.[42] Bacteriophage therapy is an 
important alternative to antibiotics in the 
current era of multidrug resistant pathogens. 
A review of studies that dealt with the 
therapeutic use of phages from 1966–1996 
and few latest ongoing phage therapy 
projects via internet showed: phages were 
used topically, orally or systemically in 
Polish and Soviet studies. The success rate 
found in these studies was 80–95% with 
few gastrointestinal or allergic side effects. 
British studies also demonstrated 
significant efficacy of phages against 
Escherichia coli, Acinetobacter spp., 
Pseudomonas spp. and Staphylococcus 
aureus. US studies dealt with improving the 
bioavailability of phage. Phage therapy may 
prove as an important alternative to 
antibiotics for treating multidrug resistant 
pathogens.[43] Discovery of the structure of 
the viral protein PlyC is allowing 
researchers to understand the way it kills a 
significant range of pathogenic bacteria. [44] 
Nonetheless there is evidence that heavy 
metals and some pollutants may select for 
antibiotic-resistant bacteria, generating a 
constant source of them in small numbers. [45] 
Constraints in Medicinal Approach 
 Inappropriate prescribing of antibiotics 
has been attributed to a number of causes, 
including people who insist on antibiotics, 
physicians who simply prescribe them as they 
feel they do not have time to explain why they 
are not necessary, and physicians who do not 
know when to prescribe antibiotics or else are 
overly cautious for medical legal reasons.[46] For 
example, a third of people believe that antibiotics 
are effective for the common cold,[47] and the 
Chakrapany Sharma et al. Antibiotic Resistant Organism: An Emerging Public Health Problem and Role 
of Ayurveda (An Overview) 
 
                                                               Available online at : http://ijapr.in Page 22 
common cold is the most common reasons 
antibiotics are prescribed[48] even though 
antibiotics are completely useless against 
viruses. The number of persons inappropriately 
prescribed antibiotics is a greater factor in the 
increasing rates of bacterial resistance rather 
than non-compliance with antibiotic protocol 
among those prescribed the drugs. However, the 
non-compliance rate is high. [49] A single dose of 
antibiotics leads to a greater risk of resistant 
organisms to that antibiotic in the person for up 
to a year. [50]  
Ayurveda view on the Exogenous Diseases: 
Ayurveda classifies the diseases, as followed: 
 Adhyatmika Vyadhi- diseases of one’s own 
body It further sub-divided into 
1. Adibala Pravratta Vyadhi (Genetic Diseases)  
Adibala Pravratta diseases are those produced 
by the abnormalities of Shukra (sperm) and 
Shonita (ova) such as leprosy, piles etc.  
These are again two kinds viz –  
1. Matraja- derived from the mother  
2. Pitraja- derived from the father. 
2. Janmabala Pravratta Vyadhi (Diseases are 
those produced by improver conduct of the 
mother) 
Janmabala Pravratta diseases are those 
produced by improver conduct of the mother, 
such as lameness, deafness, muteness, nasal 
speech, dwarfness etc. all by birth. Even these 
are of two kinds, viz.  
1. Rasakrata – produced by rasa  
2. Dauhridapachaara krita (produced by non-
fulfilling of longing of the mother during 
pregnancy). 
3. Doshabala Pravratta Vyadhi (Diseases are 
those diseases arising from improper food 
and activities)  
Doshabala Pravratta diseases are of two kinds-  
1. Amashya samuttha- (produced/born in the 
stomach and small intestine)  
2. Pakvashaya Samuttha – (produced/born in 
large intestine) 
Again these are two kinds, viz  
1. Sharira- Somatic  
2. Manasa- Psychic  
All the above are Adhyatmika diseases 
concerning ones own self. 
 Adhibhautika Vyadhi- (Diseases occurs due 
to external objects)  
The diseases occurs with the close connection to 
external objects.  
1. Sanghata bala Pravratta Vyadhi (Diseases 
which are external /accidental, caused by 
assault) 
Those diseases which are external /accidental, 
caused by assault by the strong on the weak. 
These also are two kinds-viz  
1. Shastrakratta- caused weapons  
2. Vyalakratta- caused by wild animals  
 Adhidaivika Vyadhi- (Diseases caused by 
super human agencies): Furthermore, 
Ayurveda categorizes the types of diseases 
are as bellowed;- 
1. Kalabala Pravratta Vyadhi (Seasonal 
Diseases)  
Those diseases produced by kala (season) such 
as cold, heat, wind, rain, sunlight etc. Even these 
are of two kind viz-  
1. Vyapanakratta – produced from abnormal 
seasons  
2. Avyapannakratta- produced by normal 
seasons. 
2. Davibala Pravratta Vyadhi (Diseases 
humiliated by divine or subtle beings)  
Those diseases caused by humiliated 
divine/subtle beings, by Atharvana rites 
(sorcery, witchcraft etc.) and by Upsarga 
(infections) – developing from proximity or 
contact with another disease person. These are 
also of two kinds. Viz.  
1. Vidyudarshanikratta- produced by lightning, 
thunderbolt etc.  
2. Pishachadikratta-produced by demons like 
pishacha (microbes) etc.  
3. Svabhava Bala Pravratta Vyadhi (Natural 
Disease)  
Those diseases such as hunger thirst, old-age, 
death, sleep and such other; these are also of two 
kinds. Viz.  
1. Kalaja- appearing at the proper/usual time  
2. Akalaja- appearing at improper time  
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Among these kalaja is those which appear even 
after protection and Akalaja are those which 
appear without any protection. 
Cause of All Diseases – the Dosha – 
Sarvavyadhi Karana and Doshas : For all 
disease, Vata, Pitta and Kapha only are the 
causes, because of exhibiting their features, 
result being actually seen / observed and 
because of being exhorted in the scriptures. Just 
as the myriads of substances of the universe are 
not beyond of Satva, rajas and Tamas, similarly 
the multitude of diseases cannot be beyond 
Tridosha, which are present all over the body.; 
their differentiation is done on the basis of their 
combination, association with tissues (Dhatus) 
and (excreta) Malas of their seats and of their 
causes; these are named after the particular 
Dhatu, which is vitiated greatly, such as Rasaja, 
Shonitaja, Mansaja, Medaja, Asthija, Majjaja and 
Shukraja. 
Vyadhi Utpatti Sthana- place of origin of 
disease; Diseases manifest at the place where 
the aggravated Dosha (by exogenous or 
endogenous causes) circulating all over the body 
become obstructed, due to abnormality of the 
channels. In summary, an important doctrine of 
diseases manifestation in Ayurveda; the Dosha 
get aggravated by use of improper foods and 
activities first and vitiate the kosthagni 
(Metabolic enzymes) leading to improper 
digestion production of ama (toxin) and their 
minute srotas (body channels) this is called 
shrotodushtie (Disequilibrium in channels). 
When the rasadhatu (plasma and lymph) 
containing ama (toxin) and aggravated doshas 
reaches the place where Kha Vaigunya 
(movement tendency towards empty space) has 
taken place, it being unable to get into the 
minute channels, gets obstructed, 
stagnates/accumulates there and gives rise to 
diseases.  
Shroto dushti is of four kinds 
1. Atipravratti- increase of structure and function 
of thatu vis-à-vis-organ or organ.  
2. Sanga- obstruction leading to stagnation and 
increase of size of the Dhatu or organ.  
3. Siragranthi- formation of tumour, thickening 
of the channels (Dhatus).  
4. Vimarga Gamana- action or movements of 
materials etc. inside the Dhatus happening in the 
wrong manner. This kind of movement may be 
seen in the exogenous (infectious) diseases. [51] 
Are there any 'Antibiotics' in 'Ayurveda'?: It is 
quite natural that Ayurveda, the oldest health 
care system in the world (about 5000 years old), 
will not have the word 'Antibiotics'. But a curious 
search in its literature will definitely yield 
number of references stating that certain 
diseases are produced due to micro-organisms 
and one has to destroy them to preserve the 
health. Various types of these organisms are also 
described in Veda and Ayurveda. Ex. – Arati, 
Arjun, Alinsh, kravyad etc. One interesting thing 
can be noted in these references. Ayurveda has 
not only advised on destroying these disease 
producing organisms but has also stressed that 
one should also increase the resisting power-
immunity against these organisms to prevent the 
relapses of the disease. Almost all the herbs and 
medicines suggested by Ayurveda for killing 
these germs also have the property of increasing 
the immunity. This is called 'Rasayana' in 
Ayurveda. ‘Sushruta', the father of Surgery, has 
written in detail about various surgical 
procedures and has also described number of 
techniques to prevent the infection of these 
surgical wounds. He has described various 
means for doing post operative surgical 
dressings. Disease specific recommendations of 
Ayurveda drugs for some common infectious 
diseases are as bellowed: 
A. Gold is considered as excellent antiseptic 
and has got 'Rasayana' properties also. 
Suvarna Bhasma (Gold Calx) is effectively 
used in cases of pulmonary tuberculosis. 
B. 'Mahasudarshan Kwath' has been found 
very effective in cases of Malaria and other 
P.U.O. cases without any unwanted side 
effects. 
C. Triphala guggulu is also seen to be effective 
in surgical prophylaxis. 
An Ayurvedic approach to antibiotic resistant 
microbial infections 
The methods of treatment prescribed by 
Ayurveda are meant both for the healthy and for 
the sick person. [52] Ayurveda categories the 
infectious diseases are under the Agantuj - 
“Exogenous – diseases”, which are caused by 
Close physical contacts, nail cut, teeth infections, 
fall, spell, and natural calamities. Further it says 
that these may caused of disturbance in 
equilibrium of Vata, Pitta and Kapha. Exogenous 
diseases are again two-type viz., caused by these 
three doshas and caused by vitiation of three 
doshas. [53] “Exogenous – diseases” while based 
on vitiated dosha then the each dosha share of 
symptoms with each other[54]. When an 
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individual effected once with “Exogenous – 
diseases” and ignores the proper treatment then 
these diseases may turn into Nij Vyadhi - 
“Endogenous chronic diseases” and effect to the 
immune system. Thus once natural immunity 
becomes weak then smaller disease may 
manifest as a life-threatening disease. The 
Ayurvedic approach to the prevention and 
treatment of microbial infection recognizes the 
emergency use of modern drugs, but 
recommends traditional herbal combinations 
and extracts known to balance the individual and 
improve health, as well as herbs that help to 
combat or prevent microbial infections.  
Ojas – An Overview 
Ojas or Bala is defined in Ayurveda to the natural 
immunity of a human body. There are the three 
clinical conditions viz., Ojo Visramsa, Ojo-Vyapat 
and Ojokshaya, which result due to mild, 
moderate and severe impairment in the 
availability of Ojas to the tissues. These 
conditions arise out of injury to or diseases of 
the channels of distribution of this vital 
substance, its altered composition and deficiency 
respectively. The aetiological factors which bring 
about these conditions or the causes for reduced 
immune capability, according to Ayurveda, range 
from trauma (both physical and microbial), 
severe degenerative and wasting diseases, 
malnutrition, starvation to psychological stresses 
- anger, anxiety and grief etc. These factors 
depending upon their extent, degree and 
intensity of operation may result in the 
production of one of the above mentioned 
conditions. [55] 
Practice of Immunomodulation in Ayurveda 
It is now being recognized that 
modulation of immunological response could 
provide an alternative to conventional 
chemotherapy for a variety of diseased 
conditions of impaired immune responsiveness 
or when a selective immunosuppression has to 
be induced in situations like autoimmune 
disorders and organ transplantations. The basic 
concept of immunomodulation not only existed 
in Ayurveda but is being really practiced by the 
Ayurvedists for centuries. Vyadhi-ksamatwa, as it 
is understood in Ayurveda has much wider 
implications than the term “Immunity” used in 
modern medicine. In fact, one of the therapeutic 
strategies in Ayurvedic medicines is to enhance 
the body’s overall natural resistance to the 
disease causing agent rather than directly 
neutralizing the agent itself. 
Recent Trends in Plant origin 
Immunomodulatory Drug Research and 
Ayurveda Rasayan Dravya 
The recent trend in evaluation of the 
herbal immunodulators is towards assessing the 
activity profile of the isolated principles in a 
battery of experiments with a view to identify 
the components responsible for the activity 
profile of the isolated principles in a battery of 
experiments with a view to identify the 
components responsible for the activity as also 
to understand the mechanism of their action. 
Amongst diverse class of compounds, it was 
observed the flavonol series possess the most 
potent anticomplementary activity. The potent 
antiphlogistic and antiallergic activity of the 
flavonoid wedelolactone from Rasayana drug 
Bhringraj (Eclipta alba and Wedelia 
calandulacea) was found to be due to its 5-
lipoxygenase inhibitory activity, suggesting that 
it act by free oxygen radical scavenger 
mechanism. [56] 
The active principles of Guduchi 
(Tinospora cordifolia), an important Rasayana 
drug, have been found to possess 
anticomplementary and immunostimulating 
activities. Previous studies on the extracts of 
Guduchi reported antidiabetic, anti-
inflammatory and hepatoprotective activities. 
Syringin (TC-4) inhibited the invitro 
immunohaemolysis of antibody coated 
erythrocytes. The reduced immunohaemolysis 
was found to be due to inhibition of the C3-
convertase of the classical complement pathway. 
The commounds gave rise to significant increase 
in IgG antibodies in the serum. Humoral and cell 
mediated immunity were also dose dependently 
enhanced. Macrophase activation was reported 
for cordioside (TC-2), cardiofolioside – A (TC-5) 
and Cordiol (TC- 7). These compounds induced 
significant increase in phagocytic activity by 
activation of the peritoneal macrophases. [57] 
Yastimadhu (Glycirrhiza glabra), another 
important Rasayana drug has been found to be 
immunostimulative, which accelerates 
lymphocytic transformation activation of 




   Int. J. Ayur. Pharma Research, 2014; 2(1): 17-29   ISSN: 2322 - 0910 
                                                                  Available online at : http://ijapr.in Page 25 
Review of Recent Studies carried out for MDR  
1. A study reveals that some plants of 
importance in the Ayurvedic system of 
traditional medicine used in India to treat 
enteric diseases. Fifty four plant extracts 
(methanol and aqueous) were assayed for 
their activity against multi-drug resistant 
Salmonella typhi. Strong antibacterial 
activity was shown by the methanol extracts 
of Bilva- Aegle marmelos, Shalmali - Salmalia 
malabarica, Dadim- Punica granatum, Kutaj - 
Holarrhena antidysenterica, Arjun - 
Terminalia arjuna and Triphala (mixture of 
(Amla) Emblica officinalis, (Haritaki or Harad) 
Terminalia chebula and (Vibhitak or Baheda) 
Terminalia belerica. Moderate antimicrobial 
activity was shown by Kutki - Picorhiza 
kurroa, Khadir - Acacia catechu, Babbul - 
Acacia nilotica, Vidang -Embelia ribes, 
Makoya - Solanum nigrum, Tulsi - Ocimum 
sanctum, and Palash - Butea monosperma. [59] 
2. Another study advocates using the silver for 
the treatment to M D R (Multi Drug Resistant) 
organism and refers that in the present 
scenario, pharmaceutical and biomedical 
sectors are facing the challenges of 
continuous increase in the multidrug-
resistant (MDR) human pathogenic microbes. 
Re-emergence of MDR microbes is facilitated 
by drug and/or antibiotic resistance, which is 
acquired way of microbes for their survival 
and multiplication in uncomfortable 
environments. MDR bacterial infections lead 
to significant increase in mortality, morbidity 
and cost of prolonged treatments. Therefore, 
development, modification or searching the 
antimicrobial compounds having bactericidal 
potential against MDR bacteria is a priority 
area of research. Silver in the form of various 
compounds and bhasmas have been used in 
Ayurveda to treat several bacterial infections 
since time immemorial. As several pathogenic 
bacteria are developing antibiotic resistance, 
silver nanoparticles are the new hope to treat 
them. This review discusses the bactericidal 
potential of silver nanoparticles against the 
MDR bacteria. This multiactional nanoweapon 
can be used for the treatment and prevention 
of drug-resistant microbes. [60] 
3. A study has found that Manuka honey could 
help in clearing chronically infected wounds, 
and even in reversing bacterial resistance to 
antibiotics. Professor Rose Cooper from the 
University of Wales Institute Cardiff is looking 
at how Dry grapes and honey interacts with 
three types of bacteria that commonly infest 
wounds: Pseudomonas aeruginosa, Group A 
Streptococci and Meticillin-resistant 
Staphylococcus aureus (MRSA). Her group has 
found that honey can interfere with the 
growth of these bacteria in a variety of ways 
and suggests that honey is an attractive 
option for the treatment of drug-resistant 
wound infections. Honey has long been 
acknowledged for its antimicrobial properties. 
Traditional remedies containing honey were 
used in the topical treatment of wounds by 
diverse ancient civilizations. Manuka honey is 
derived from nectar collected by honeybees 
foraging on the manuka tree in New Zealand 
and is included in modern licensed wound-care 
products around the world. However, the 
antimicrobial properties of honey have not 
been fully exploited by modern medicine, as 
its mechanisms of action are not yet known. 
Cooper`s group is helping to solve this 
problem by investigating at a molecular level 
the ways in which manuka honey inhibits 
wound-infecting bacteria. [61] 
4. A study was conducted in Sri Lanka to 
determine antimicrobial activity of selected 
Ayurvedic preparations against bacteria and 
fungi and it refers that: “increasing 
antimicrobial resistance exhibited by 
microorganisms causing superficial skin 
infections has led to extensive research on the 
therapeutic potential of Ayurvedic 
preparations. Medicinal plants contain many 
types of naturally occurring and side effects-
free anti microbial compounds that can be 
effectively used against microbial infections. 
Antimicrobial activity of twenty-eight 
Ayurvedic preparations used to treat 
superficial infections in a local Ayurvedic 
healthcare institution were tested against 
Trichophyton rubrum, Microsporum gypseum, 
Candida albicans, Malassezia furfur, 
Staphylococcus aureus and Streptococcus 
pyogenes. Twelve preparations showed 
significant antimicrobial activity and gave 
inhibition zones >10 mm. Two Ayurvedic 
preparations (Mixture containing Terminella 
chebula, Terminella bellerica and Emblica 
officinalis and one of Terminella chebula only) 
showed antimicrobial activity against all the 
microorganisms tested.”  
5. One more Ayurveda herb “Rason” or Lahasun 
(A. sativum) was studied and concluded that 
the it was tested against gram-positive and 
gram-negative bacterial isolates from Urinary 
Tract of Indian patients, which were 
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confirmed for resistant against commonly 
used antibiotics for urinary tract infections. In 
this study, only five quantities (10, 20, 30, 40 
and 50µg) of aqueous allicin from A. sativum 
cloves and leaves were used, which has 
antibacterial activity against test isolates by 
disc diffusion method. The maximum 
inhibitory activity of allicin against all test 
isolates was observed at 40µg and the 
quantity was found statistically significant (P< 
0.01) for antibacterial activity of allicin 
extracted from A. sativum cloves and leaves 
against UT bacterial isolates. [62] 
6. Several Ayurveda plants extracts have 
exhibited synergistic activity against 
microorganisms. The Ayurveda plants 
possessing significant anti-microbial activity 
are neem (Azadirachta indica), Krishna-
marich (Piper longum), Guduchi stem 
(Tinospora cordifolia) and amla fruit (Emblica 
officinalis). Thus it can be said that the 
Ayurveda herbs may play a vital role to the 
treatment of antibiotic resistant microbial 
infections. [63]  
CONCLUSION 
It can be concluded that there is evidence 
that naturally occurring antibiotic resistance is 
common. A single dose of antibiotics leads to a 
greater risk of resistant organisms to that 
antibiotic in the person. Antibiotic resistance has 
been shown to increase with duration of 
treatment. The term "superbug" is a nonspecific 
word that is used to describe any microorganism 
that is resistant to at least one or more 
commonly used antibiotics.  
In medicine, the major problem of the 
emergence of resistant bacteria is due to misuse 
and overuse of antibiotics. WHO has declared the 
“Superbug” as a threat which may be major 
cause of human death? Role of alternative 
therapies is being explored. Prevention and 
phag-therapy are in focus yet now. The 
Ayurvedic approach to the prevention and 
treatment of microbial infection recognizes the 
emergency use of modern drugs, but 
recommends traditional herbal combinations 
and extracts known to balance the individual and 
improve health, as well as herbs that help to 
combat or prevent microbial infections. Several 
plant extracts have exhibited synergistic activity 
against microorganisms. In nut and shell it can 
be said that the Ayurveda’s emphasis on the role 
of Doshas and their imbalance as the main 
causative factor of the diseases assumes 
importance in the light of the fact that mere 
presence of causative organisms in the 
environment does not necessarily results in the 
manifestation of the disease. The concepts of 
Ojas and Bala, of the inherent immunological 
capabilities including innate immunity and 
acquired immunity in terms of Sahajabala and 
Yuktikritabala etc., playing key role in the health 
and disease have to be understood and 
appreciated by the modern immunolgists. There 
is urgent need of time to switchover on this 
serious issue for finding an effective and safe 
remedy. Ayurveda may play a vital role in this 
regard.  
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